HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
- £17.26m
- £18.92m
RCS - Hemogenyx Pharma Plc - Immuno-Oncology Summit Europe Presentation
AnnouncementREG - Hemogenyx Pharma Plc - Final Results for the Year Ended 31 December 2021
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementREG - Hemogenyx Pharma Plc - CBR Update
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementRCS - Hemogenyx Pharma Plc - HEMO-CAR-T pre-IND Meeting Request
AnnouncementREG - Hemogenyx Pharma Plc - Hemogenyx Pharmaceuticals Partnership with Selexis
AnnouncementRCS - Hemogenyx Pharma Plc - H.C. Wainwright Bioconnect Conference
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Second Price Monitoring Extn
AnnouncementREG - Hemogenyx Pharma Plc - Price Monitoring Extension
AnnouncementREG - Hemogenyx Pharma Plc - Hemo-CAR-T partnership with WuXi ATU
Announcement